The mechanism involved the downregulation of Krüppel-like factor 4 (KLF4), an oncogene-acting gene in BC, and HDAC2 and HDAC3 activity, whose inhibitor-mediated inhibition is dependent on KLF4. Here, KLF4 is linked to breast cancer.